Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among […]
Related Keywords
, Codexis Inc , Vanguard Group Inc , Opaleye Management Inc , Nasdaq , Nantahala Capital Management , Blackrock Inc , Get Free Report , Capital Management , Opaleye Management , Get Free , Performance Enzymes , Codexis Daily , Codexis , Nasdaq Cdxs , Cdxs , Medical , 19200510 , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.